Hung-Wei Wang

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Metastatic Colorectal Cancer

Top Venues

Current oncology (Toronto, Ont.)

Journal of gastroenterology and hepatology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ying-Chun Shen, Tsung-Hao Liu, Alan Nicholas, Akihiko Soyama, Chang-Tsu Yuan, Tse-Ching Chen, Susumu Eguchi, Tomoharu Yoshizumi, Shinji Itoh, Noriaki Nakamura, Hisashi Kosaka, Masaki Kaibori, Takamichi Ishii, Etsuro Hatano, Chikara Ogawa, Atsushi Naganuma, Satoru Kakizaki, Chih-Hsien Cheng, Po-Ting Lin, Yung-Yeh Su, Chien-Huai Chuang, Li-Chun Lu, Chi-Jung Wu, Hung-Wei Wang, Kun-Ming Rau, Chih-Hung Hsu, Shi-Ming Lin, Yi-Hsiang Huang, Sairy Hernandez, Richard S Finn, Masatoshi Kudo, Ann-Lii Cheng
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Che-Jui Chang, Wei-Fan Hsu, Long-Bin Jeng, Hsueh-Chou Lai, Shih-Chao Hsu, Te-Hung Chen, Hung-Wei Wang, Cheng-Yuan Peng
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current oncology (Toronto, Ont.) 30 (12) (2023)
Che-Jui Chang, Wei-Fan Hsu, Long-Bin Jeng, Hsueh-Chou Lai, Shih-Chao Hsu, Te-Hung Chen, Hung-Wei Wang, Cheng-Yuan Peng
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current oncology (Toronto, Ont.) 30 (12) (2023)
Che-Jui Chang, Wei-Fan Hsu, Long-Bin Jeng, Hsueh-Chou Lai, Shih-Chao Hsu, Te-Hung Chen, Hung-Wei Wang, Cheng-Yuan Peng
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current oncology (Toronto, Ont.) 30 (12) (2023)
Che-Jui Chang, Wei-Fan Hsu, Long-Bin Jeng, Hsueh-Chou Lai, Shih-Chao Hsu, Te-Hung Chen, Hung-Wei Wang, Cheng-Yuan Peng
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current oncology (Toronto, Ont.) 30 (12) (2023)
Che-Jui Chang, Wei-Fan Hsu, Long-Bin Jeng, Hsueh-Chou Lai, Shih-Chao Hsu, Te-Hung Chen, Hung-Wei Wang, Cheng-Yuan Peng
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion. Current oncology (Toronto, Ont.) 30 (12) (2023)
Wei-Fan Hsu, Shih-Chao Hsu, Te-Hong Chen, Chien-Hung Lin, Ying-Chun Lin, Yu-Wei Chang, Hung-Wei Wang, Yu-Min Liao, Hsueh-Chou Lai, Cheng-Yuan Peng
Modified Albumin-Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy. Cancers 14 (20) (2022)
Wei-Fan Hsu, Hsueh-Chou Lai, Po-Heng Chuang, Wen-Pang Su, Sheng-Hung Chen, Hung-Yao Chen, Hung-Wei Wang, Guan-Tarn Huang, Cheng-Yuan Peng
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agents. Journal of viral hepatitis 29 (9) (2022)
Hung-Wei Wang, Po-Heng Chuang, Wen-Pang Su, Jung-Ta Kao, Wei-Fan Hsu, Chun-Che Lin, Guan-Tarn Huang, Jaw-Town Lin, Hsueh-Chou Lai, Cheng-Yuan Peng
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma. Cancers 13 (15) (2021)
Hung-Wei Wang, Hsueh-Chou Lai, Tsung-Hui Hu, Wen-Pang Su, Sheng-Nan Lu, Chia-Hsin Lin, Chao-Hung Hung, Po-Heng Chuang, Jing-Houng Wang, Mei-Hsuan Lee, Chien-Hung Chen, Cheng-Yuan Peng
On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma. Cancers 12 (5) (2020)
Hung-Wei Wang, Hsueh-Chou Lai, Tsung-Hui Hu, Wen-Pang Su, Sheng-Nan Lu, Chia-Hsin Lin, Chao-Hung Hung, Po-Heng Chuang, Jing-Houng Wang, Mei-Hsuan Lee, Chien-Hung Chen, Cheng-Yuan Peng
Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy. Journal of gastroenterology and hepatology 34 (2) (2018)